通化金马：新药琥珀八氢氨吖啶片目前处于正常的审评过程中

Core Viewpoint - Tonghua Golden Horse (000766) is currently undergoing the normal review process for its new drug, Amber Tetrahydroaminoacridine Tablets, and will disclose relevant information according to regulations [1] Group 1 - The new drug is in the standard evaluation phase as confirmed by the company on August 14 [1] - The company will provide updates on the new drug's review progress based on the public information from the drug review center [1] - Investors are advised to pay attention to the company's announcements for further details [1]